Barclays’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $487K | Sell |
|
|||||
|
2025
Q2 | $428K | Buy |
|
|||||
|
2025
Q1 | $1.11M | Sell |
|
|||||
|
2024
Q4 | $2.94M | Buy |
|
|||||
|
2024
Q3 | $2.86M | Buy |
|
|||||
|
2024
Q2 | $2.81M | Buy |
|
|||||
|
2024
Q1 | $2.84M | Sell |
|
|||||
|
2023
Q4 | $5.32M | Buy |
|
|||||
|
2023
Q3 | $3.16M | Buy |
|
|||||
|
2023
Q2 | $2.85M | Sell |
|
|||||
|
2023
Q1 | $2.76M | Sell |
|
|||||
|
2022
Q4 | $3.53M | Buy |
|
|||||
|
2022
Q3 | $2.39M | Buy |
|
|||||
|
2022
Q2 | $1.61M | Sell |
|
|||||
|
2022
Q1 | $8.02M | Buy |
|
|||||
|
2021
Q4 | $9.59M | Buy |
|
|||||
|
2021
Q3 | $5.99M | Buy |
|
|||||
|
2021
Q2 | $2M | Buy |
|
|||||
|
2021
Q1 | $1.8M | Sell |
|
|||||
|
2020
Q4 | $3.59M | Sell |
|
|||||
|
2020
Q3 | $2.25M | Buy |
|
|||||
|
2020
Q2 | $1.32M | Sell |
|
|||||
|
2020
Q1 | $3.46M | Buy |
|
|||||
|
2019
Q4 | $754K | Buy |
|
|||||
|
2019
Q3 | $208K | Sell |
|
|||||
|
2019
Q2 | $329K | Buy |
|
|||||
|
2019
Q1 | $376K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $417K | Buy |
|
|||||
|
2018
Q2 | $160K | Sell |
|
|||||
|
2018
Q1 | $677K | Buy |
|
|||||
|
2017
Q4 | $69K | Buy |
|
|||||
|
2017
Q3 | $0 | Sell |
|
|||||
|
2017
Q2 | $53K | Buy |
|
|||||
|
2017
Q1 | $29K | Sell |
|
|||||
|
2016
Q4 | $134K | Buy |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $2K | Buy |
|
|||||
|
2016
Q1 | $1K | Sell |
|
|||||
|
2015
Q4 | $5K | Buy |
|